Author

S. Aso

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

A. Alay· 1 shared A. Dawson· 1 shared A. Fueki· 1 shared A. Sharkley· 1 shared A. Vidal· 1 shared A. Villanueva· 1 shared C. Munoz-Pinedo· 1 shared D. Cordero· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Alay

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

UGGT1-mediated reglucosylation of N-glycan competes with ER-associated degradation of unstable and misfolded glycoproteins

S. Ninagawa, M. Matsuo, D. Ying, S. Oshita, S. Aso, K. Matsushita, M. Taniguchi, A. Fueki, M. Yamashiro, K. Sugasawa, S. Saito, K. Imami, Y. Kizuka, T. Sakuma, T. Yamamoto, , K. Mori

This study shows UGGT1 reglucosylation competes with EDEM-mediated degradation of misfolded glycoproteins, influencing ER protein quality control.

bioRxiv · Oct 18, 2023Cell Biology

Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma

E. Aliagas, A. Alay, M. Martinez-Iniesta, M. Hernandez-Madrigal, D. Cordero, M. Gausachs, E. Pros, M. Saigi, S. Busacca, A. Sharkley, A. Dawson, R. Palmero, S. Padrones, S. Aso, I. Escobar, , E. Nadal

This study evaluates CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma, finding they reduce tumor growth and improve survival by inducing cell cycle arrest and senescence.

bioRxiv · Feb 8, 2021 · PreprintCancer Biology